JUNS Jupiter Neurosciences, Inc.

Fundamentals / CIK 0001679628 / USD

Jupiter Neurosciences, Inc. reported $22K in revenue and a net loss of $14.14M for the fiscal year ended December 31, 2025, with a 80.6% gross margin and a -61068.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open JUNS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$934K$467K$0-$8.08MFY 2023 Net Income: -$4.78M2023FY 2024 Revenue: $0FY 2024 Net Income: -$2.44M2024FY 2025 Revenue: $22KFY 2025 Net Income: -$8.64M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $22K $0 --
Cost of Revenue $4.2K -- --
Gross Profit $18K -- --
Research & Development $2.09M $493K $955K
Selling, General & Admin $6.84M -- --
Total Operating Expenses $8.93M $3.09M $3.87M
Operating Income -$8.91M -$3.09M -$3.87M
Interest Income -- $5.6K $482
Interest Expense $66K $248K $219K
Net Income -$8.64M -$2.44M -$4.78M
Basic EPS -$18.80 -$6.01 -$13.53
Diluted EPS -$18.80 -$6.01 -$13.53
Basic Shares Outstanding 460.6K 382.8K 351.2K
Diluted Shares Outstanding 460.6K 382.8K 351.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $14K $24K $19K -- -- -- $0 --
Cost of Revenue $4.3K $3.2K $4.4K -- -- -- -- --
Gross Profit $9.6K $21K $14K -- -- -- -- --
Research & Development $3.89M $600K $411K $44K $817K $759K $467K $201K
Selling, General & Admin $1.91M $2.16M $1.57M -- -- -- -- --
Total Operating Expenses $5.81M $2.76M $1.98M $2.83M $2.30M $2.26M $1.54M $1.46M
Operating Income -$5.80M -$2.74M -$1.96M -$2.81M -$2.30M -$2.26M -$1.54M -$1.46M
Interest Income $7.2K $10K $18K -- $10K $13K $10K $5.4K
Interest Expense $68K $91K $119K $62K $1.2K $1.1K $1.2K $31K
Net Income -$7.22M -$2.27M -$2.06M -$2.58M -$2.29M -$2.25M -$1.53M -$1.53M
Basic EPS -$7.42 -$4.08 -$4.51 -- -$5.04 -$5.09 -$3.76 --
Diluted EPS -$7.42 -$4.08 -$4.51 -- -$5.04 -$5.09 -$3.76 --
Basic Shares Outstanding 973.6K 557.6K 468.9K -- 453.9K 442.4K 440.3K --
Diluted Shares Outstanding 973.6K 557.6K 468.9K -- 453.9K 442.4K 440.3K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.79M $3.77M $28K
Cash & Short-Term Investments $3.79M $3.77M $28K
Accounts Receivable, Net $2.6K -- --
Inventory $160K -- --
Other Current Assets $107K $114K $261
Total Current Assets $4.82M $4.65M $29K
Other Non-Current Assets $3.8K $3.8K $3.8K
Total Non-Current Assets $739K $1.55M $120K
Total Assets $5.56M $6.20M $149K
Accounts Payable $131K $279K $189K
Deferred Revenue (Current) $735 -- --
Total Current Liabilities $7.40M $2.01M $5.77M
Total Non-Current Liabilities $0 $21K $178K
Total Liabilities $7.40M $2.03M $5.95M
Total Debt (incl. Leases) $21K $71K $120K
Common Stock $46 $3.3K $2.7K
Retained Earnings -$34.67M -$26.02M -$23.58M
Total Stockholders' Equity -$1.83M $4.17M -$5.80M
Total Equity -$1.83M $4.17M -$5.80M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $301K $1.52M $2.36M $3.79M $724K $1.88M $2.71M $3.77M
Cash & Short-Term Investments $301K $1.52M $2.36M $3.79M $724K $1.88M $2.71M $3.77M
Accounts Receivable, Net -- $10K -- $2.6K -- -- -- --
Inventory $131K $135K $148K $160K -- -- -- --
Other Current Assets $60K $115K $133K $107K $142K $174K $138K $114K
Total Current Assets $1.26M $2.55M $3.41M $4.82M $1.63M $2.82M $3.61M $4.65M
Other Non-Current Assets $15K $618K $3.8K $3.8K $3.8K $3.8K $3.8K $3.8K
Total Non-Current Assets $365K $1.17M $538K $739K $944K $1.15M $1.35M $1.55M
Total Assets $1.62M $3.72M $3.95M $5.56M $2.58M $3.97M $4.96M $6.20M
Accounts Payable $269K $360K $92K $131K $367K $465K $158K $279K
Deferred Revenue (Current) -- $859 -- $735 $6.7K -- -- --
Total Current Liabilities $2.59M $3.88M $6.73M $7.40M $2.52M $2.63M $1.89M $2.01M
Total Non-Current Liabilities $198K $205K $0 $0 $0 $0 $8.5K $21K
Total Liabilities $2.79M $4.08M $6.73M $7.40M $2.52M $2.63M $1.90M $2.03M
Total Debt (incl. Leases) $225K $221K $8.5K $21K $34K $46K $59K $71K
Common Stock $132 $66 $3.6K $46 $3.4K $3.5K $3.3K $3.3K
Retained Earnings -$46.23M -$39.00M -$36.73M -$34.67M -$32.09M -$29.80M -$27.55M -$26.02M
Total Stockholders' Equity -$1.16M -$366K -$2.78M -$1.83M $57K $1.34M $3.06M $4.17M
Total Equity -$1.16M -$366K -$2.78M -$1.83M $57K $1.34M $3.06M $4.17M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$8.64M -$2.44M -$4.78M
Stock-Based Compensation $2.42M $1.84M $1.20M
Change in Receivables -$2.6K -- --
Change in Inventory -$160K -- --
Operating Cash Flow -$5.41M -$3.91M -$481K
Common Stock Issued -- $150K $55K
Financing Cash Flow $5.43M $7.65M $445K
Net Change in Cash $20K $3.74M -$36K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.22M -$2.27M -$2.06M -$2.58M -$2.29M -$2.25M -$1.53M -$1.53M
Stock-Based Compensation $552K $491K $501K $463K $1.07M $462K $421K $1.01M
Change in Receivables $10K -$10K $2.6K -- -- -- -- --
Change in Inventory $4.3K $13K $12K -- -- -- -- --
Operating Cash Flow -$2.72M -$2.29M -$1.43M -$2.37M -$1.15M -$828K -$1.06M -$3.70M
Financing Cash Flow $1.50M $1.45M $5.5K -- -- -- -- $7.47M
Net Change in Cash -$1.22M -$841K -$1.43M $3.07M -$1.15M -$828K -$1.06M $3.77M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 80.6% -- --
Operating Margin -40873.2% -- --
Net Profit Margin -39662.8% -- --
Return on Equity (ROE) -- -58.5% --
Return on Assets (ROA) -155.4% -39.3% -3219.3%
Current Ratio 0.65x 2.31x 0.00x
Quick Ratio 0.63x 1.88x 0.00x
Debt to Equity -- 0.02x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -13232.1% -440.3% -108.8% -58.5%
Return on Assets (ROA) -870.9% -247.4% -232.4% -155.4% -294.9% -148.7% -67.2% -39.3%
Current Ratio 0.49x 0.66x 0.51x 0.65x 0.65x 1.07x 1.91x 2.31x
Quick Ratio 0.44x 0.62x 0.48x 0.63x 0.29x 0.71x 1.43x 1.88x
Debt to Equity -- -- -- -- 0.59x 0.03x 0.02x 0.02x
Net Income Growth (YoY) -- -- -- -- -- -819.5% -- --
EPS Growth (YoY) -- -- -- -- -- -777.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001679628) · from March 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:11 UTC · Open in terminal